Optvel-DX Eye Drop is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone 0.1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial ocular infections accompanied by inflammation, such as conjunctivitis, keratitis, and postoperative ocular inflammation. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible pathogens. Concurrently, Dexamethasone reduces inflammation by suppressing the release of inflammatory mediators, decreasing edema, redness, and discomfort. Optvel-DX Eye Drop is typically administered as one to two drops into the affected eye(s) every four to six hours, with dosage adjusted based on clinical response and severity of infection. Caution is advised in patients with viral or fungal ocular infections, as corticosteroids may exacerbate these conditions. Prolonged use may increase the risk of elevated intraocular pressure, cataract formation, or secondary infections. Patients should be monitored regularly during therapy. This combination provides a synergistic approach to managing bacterial eye infections with inflammatory components, promoting rapid symptom resolution and improved patient outcomes.